SPARC and neoplasm: The modification of lactoferrin and the adsorption of endogenous albumin have a dual-targeting effect on the receptors of both LRP1 and Secreted protein acidic and rich in cysteine (SPARC), which are overexpressed in tumor cells and immune cells.